TILMIUS

Serial Number 88816766
Registration 6727065
700

Registration Progress

Application Filed
Mar 2, 2020
Under Examination
Approved for Publication
Jul 7, 2020
Published for Opposition
Jul 7, 2020
Registered
May 24, 2022

Trademark Image

TILMIUS

Basic Information

Serial Number
88816766
Registration Number
6727065
Filing Date
March 2, 2020
Registration Date
May 24, 2022
Published for Opposition
July 7, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 24, 2022
Registration
Registered
Classes
005

Rights Holder

Fresenius Kabi Deutschland GmbH

16
Address
Else-Kröner-Str. 1
Bad Homburg 61352
DE

Ownership History

Fresenius Kabi Deutschland GmbH

Original Applicant
16
Bad Homburg DE

Fresenius Kabi Deutschland GmbH

Owner at Publication
16
Bad Homburg DE

Fresenius Kabi Deutschland GmbH

Original Registrant
16
Bad Homburg DE

Legal Representation

Attorney
SCOTT D. WOLDOW

USPTO Deadlines

Next Deadline
937 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-05-24)
Due Date
May 24, 2028
Grace Period Ends
November 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
May 24, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 24, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 12, 2022 OP.T T OPPOSITION TERMINATED NO. 999999 Loading...
Apr 12, 2022 OP.D T OPPOSITION DISMISSED NO. 999999 Loading...
Apr 12, 2022 TMBN T TTAB RELEASE CASE TO TRADEMARKS Loading...
Oct 27, 2020 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Jul 9, 2020 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jul 7, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 7, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 17, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 29, 2020 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
May 29, 2020 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
May 21, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 21, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 21, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 19, 2020 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Apr 20, 2020 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Apr 20, 2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 20, 2020 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 18, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 7, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 5, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis; pharmaceutical preparations for the treatment of CAR T-cell induced cytokine release syndrome, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis

Classification

International Classes
005